These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 6331296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The action of combinations of the nonapeptide polymyxin B with antibiotics on gram-negative bacteria].
    Bairamashvili DI, Zinchenko AA, Maslin DN, Trakhanova MN, Miroshnikov AI.
    Antibiot Khimioter; 1988 Aug; 33(8):591-4. PubMed ID: 2848467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM, Belobraydic KA.
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [Abstract] [Full Text] [Related]

  • 7. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J, Shah N, Kelly P, Babu E, Backer M, Rosas-Garcia G, Salamera J, George A, Bratu S, Landman D.
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [Abstract] [Full Text] [Related]

  • 8. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C, Hildebrandt J, Schütze E, Wenzel AF.
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [Abstract] [Full Text] [Related]

  • 9. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.
    Vaara M, Porro M.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1801-5. PubMed ID: 8843284
    [Abstract] [Full Text] [Related]

  • 10. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
    Vaara M, Fox J, Loidl G, Siikanen O, Apajalahti J, Hansen F, Frimodt-Møller N, Nagai J, Takano M, Vaara T.
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3229-36. PubMed ID: 18591267
    [Abstract] [Full Text] [Related]

  • 11. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM, Lafontaine AJ, Herrera CM, Mclean AB, Trent MS.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31844003
    [Abstract] [Full Text] [Related]

  • 12. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265
    [Abstract] [Full Text] [Related]

  • 13. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ, Jo J, Kim J, Ko KS, Lee W.
    Microbiol Spectr; 2024 Apr 02; 12(4):e0368723. PubMed ID: 38391225
    [Abstract] [Full Text] [Related]

  • 14. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
    Gales AC, Jones RN, Sader HS.
    Clin Microbiol Infect; 2006 Apr 02; 12(4):315-21. PubMed ID: 16524407
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
    Vaara M, Sader HS, Rhomberg PR, Jones RN, Vaara T.
    J Antimicrob Chemother; 2013 Mar 02; 68(3):636-9. PubMed ID: 23134658
    [Abstract] [Full Text] [Related]

  • 17. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J, Finley F.
    J Infect Dis; 1979 Oct 02; 140(4):581-9. PubMed ID: 229175
    [Abstract] [Full Text] [Related]

  • 18. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct 02; 56(5):458-96. PubMed ID: 14692381
    [Abstract] [Full Text] [Related]

  • 19. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ, Karaaslan E.
    Infect Dis (Lond); 2019 Sep 02; 51(9):676-682. PubMed ID: 31298061
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
    Rizek C, Ferraz JR, van der Heijden IM, Giudice M, Mostachio AK, Paez J, Carrilho C, Levin AS, Costa SF.
    J Infect Chemother; 2015 Feb 02; 21(2):114-7. PubMed ID: 25456893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.